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In 2006, the Chief Medical Ofﬁcer’s report Good Doctors,
Safer Patients1 called for the reinvigoration of clinical audit
to support better patient care and service improvement,
and also to be an integral part of the revalidation of
clinicians. The Royal College of Psychiatrists’ guidance on
revalidation2 includes the requirement to participate in
clinical audit. For trainees, participation in audit can allow a
number of intended learning outcomes3 to be achieved. These
include gaining an understanding of how clinical governance
can be applied in practice, and the development of leadership
skills related to monitoring performance and effecting change.
The National Institute for Health and Care Excellence
(NICE)4 deﬁned clinical audit as a ‘quality improvement
process that seeks to improve patient care and outcomes
through systematic review of care against explicit criteria
and the implementation of change’. This suggests that
clinical audit should be seen primarily as a tool for
quality improvement. By auditing clinical practice against
standards derived from evidence-based guidelines, such as
those developed by NICE, deﬁned aspects of the quality of
care delivered to patients can be measured and monitored.
The Royal College of Psychiatrists’ guidance emphasises
that it is not direct involvement in data collection that is
important, but rather the review of the audit evidence for
the quality of care provided, and taking the lead in
implementing strategies to improve quality where these
are required. Such reﬂection on the data by clinicians is
perhaps the most potent aspect of clinical audit.
It is important to note that although audit can generate
new knowledge, its primary purpose is to compare practice
against pre-determined standards. Taking the example of a
clinical audit of monitoring of lithium treatment, data
would generally be collected directly from clinical records5
although questionnaires might be administered for particular
purposes, such as gauging patients’ knowledge about the
necessary tests or clinicians’ views on responsibility for
long-term monitoring. Patients should be receiving usual
care. The boundaries between audit, service evaluation and
research can be blurred. A brief summary of the differences
has been produced by the Royal College of Psychiatrists’
Centre for Quality Improvement6 but if there is any doubt
about the status of an individual project, advice should be
sought from the relevant trust’s audit and research and
development departments.
Choosing an audit topic
Audit is most rewarding when it can drive improvements
that have a positive impact on patient care and ultimately
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Summary Audit is an important tool for quality improvement. The collection of data
on clinical performance against evidence-based and clinically relevant standards,
which are considered by clinicians to be realistic in routine practice, can usefully
prompt reﬂective practice and the implementation of change. Evidence of
participation in clinical audit is required to achieve intended learning outcomes for
trainees in psychiatry and revalidation for those who are members of the Royal
College of Psychiatrists. This article addresses some of the practical steps involved in
conducting an audit project, and, to illustrate key points, draws on lessons learnt from
a national, audit-based, quality improvement programme of lithium prescribing and
monitoring conducted through the Prescribing Observatory for Mental Health.
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on outcomes. As a general rule, if the practice being audited
is high volume, high risk or high cost, it is likely to be of
importance to the trust as a whole and to patients. Trust
priorities for audit are often driven by the requirement to
evidence the implementation of NICE guidelines but other
legitimate sources include local CQUINS (Commissioning
for Quality and Innovation7), the requirements of the Care
Quality Commission8 (CQC), the National Health Service
Litigation Authority9 (NHSLA), the Mental Health Act 1983
code of practice10 or the ﬁndings of primary research.
Lithium treatment is a good example of an appropriate
focus for audit.5 It is a high-volume and high-risk treatment
and clear standards can be derived from the NICE guideline
for the management of bipolar disorder11 and a National
Patient Safety alert entitled Safer Lithium Therapy.12
Deriving audit standards
The deﬁnition of audit includes the use of explicit
performance criteria, usually in the form of practice
standards. By deﬁnition, such standards should be met
100% of the time. It is essential that when standards are
deﬁned for an audit they are both evidence based and
clinically credible, in that clinicians agree that these
standards should always be met in routine clinical practice
and it is realistic to do so. Aspirational or controversial
standards could undermine the credibility of an audit and
limit clinical engagement.
Using lithium treatment again as an example, few
clinicians would disagree that checks on renal and thyroid
function should be undertaken before lithium is prescribed,
that patients should be given information that allows them
to use lithium safely (for example, advice on avoiding
dehydration and recognising the symptoms of lithium
toxicity), and that serum lithium levels should be kept
within the therapeutic range. However, many clinicians may
disagree with the recommendation from NICE11 that serum
lithium should be checked in all patients every 3 months.
You may therefore decide that 3-monthly monitoring of
serum lithium, although not fulﬁlling criteria for a standard,
may still be useful as a clinically relevant ‘treatment target’
measure. This recognises that such frequent monitoring
may not be warranted in all patients, but clinicians may still
be interested in how their practice in this regard compares
with that of their peers.
Deciding what data to collect
It is important that the audit is practical and feasible in that
the clinical practice of interest can be measured reasonably
reliably and data collection is not too onerous a task. The
data collected must, as a minimum, enable performance
against the audit standards to be determined. Contextual
data can also be important for analysis of the audit data.
For example, with respect to lithium treatment, it is
possible that practice will differ between in-patients and
out-patients or that monitoring will be more assiduous in
elderly people or those with known renal impairment. It is
therefore reasonable to collect data related to patient
setting, age and renal status. Although the amount and
breadth of data collected should be sufﬁcient for
understanding the nature and quality of practice, there is
also a need to minimise the collection of data that is
unlikely to be of use, unlikely to be reliable, particularly
time consuming to gather, or likely to be available for only a
proportion of the patient sample. If you are unsure, seek
advice from the clinical audit department in your trust,
rather than spend time collecting information that will be
difﬁcult if not impossible to interpret in the context of the
audit.
Developing a data-collection tool
Effective data-collection tools are time consuming and
difﬁcult to design. The question for each data ﬁeld needs to
be as clear and unambiguous as possible so that there is no
doubt about what is being measured. If there is any
ambiguity, it is probable that data will be collected in an
unstandardised way and will therefore be uninterpretable.
For example, if you were interested in the monitoring of
renal function in patients treated with lithium, it would be
best to ask explicitly whether a measure of estimated
glomerular ﬁltration rate or creatinine clearance were
documented in the clinical records. A vague, poorly
worded question could lead to a positive answer on the
assessment of renal function even though the assessment
had been limited to investigation of electrolytes and urea, or
an entry in the clinical records stating that investigations
had been requested but without any documented results.
Selecting an audit sample
The audit standards should guide the selection of the
sample. For example, if you were interested in whether
screening tests were conducted before lithium treatment
was initiated, it might be most appropriate to identify a
sample from acute in-patient wards. If the focus were
monitoring of established treatment, a community sample
might be more suitable. Your trust’s informatics department
may be able to give you a list of all patients with a given
diagnosis but are unlikely to be able to identify only those
prescribed lithium. You may be able to obtain a list of
patients prescribed lithium through a local lithium
clinic, pharmacy dispensing records or a manual search of
in-patient prescription charts. Each method has limitations
and some methods will require help from other members of
staff/departments. Make sure you plan this in good time.
Organising data collection
Estimate the time it will take to collect the data you require
and test this by piloting the data-collection tool on a
small sample of cases. This will serve the dual purpose
of determining whether the questions are clear and
unambiguous, and whether the data you require can be
found in a timely manner. If it seems unrealistic for you to
complete the planned data collection on your own, you may
decide to restrict the focus of the audit or enlist help from
someone with the appropriate experience, skills and
knowledge.
The source(s) of data should be decided in advance,
determined by the audit standards chosen. For example, in a
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patient recently initiated on lithium treatment, searching
the clinical record for an entry that stated the patient had
been given information about the therapy would be an audit
of documentation of clinical practice. If you then asked the
clinical team whether the patient had been given a copy of
the National Patient Safety Agency patient lithium pack or
local alternative, this would be a direct audit of clinical
practice.
Analysing the data and interpreting the ﬁndings
For the majority of audits it is likely that the data collected
will need to be entered onto an electronic spreadsheet to
facilitate the generation of charts and ﬁgures and, if
appropriate, to allow the use of a statistical package. Data
entry is time consuming and error prone, and the accuracy
of the entered data will need to be checked.
It is advisable to follow a formal analysis plan, which
has been determined by the audit questions. It is possible to
spend a great deal of time conducting analyses that are not
appropriate, and if you need help or advice, this may be
requested from your trust’s clinical audit, research and
development or informatics departments.
With respect to stand-alone, local audits, it can be
difﬁcult to interpret the ﬁndings, particularly if the sample
size is small. For example, if you were to ﬁnd that only 80%
of patients had a check of renal function before starting
lithium treatment you might be uncertain about whether
this represented good, bad or indifferent practice. Although
clearly short of adherence with the audit standard, such a
proportion would be put in context by comparison with
equivalent data from other services and an understanding of
the clinical variables associated with performance on the
standard. This is possible with participation in a national
audit of lithium monitoring, such as that organised by the
Prescribing Observatory for Mental Health5,13 (POMH-UK),
where a standard data-collection tool is used across the
country and the data are analysed to provide benchmarking
across trusts and between clinical teams within trusts. Such
national audits, conducted for the purpose of quality
improvement, generate data intended for internal use
within a clinical team or trust to prompt reﬂective practice
and local learning. The data may not be robust enough to be
suitable for ranking or judgement14 and it is important that
this is understood by those who wish to use or act on the
audit ﬁndings.
Disseminating an audit report
It is important to consider who needs to see the audit
ﬁndings and why. The data will be more meaningful to
clinical teams if they are presented in a clear, succinct,
comprehensible and accessible manner. If the main aim of
the audit is to assess performance against a few key
standards, try to ensure that such performance is clearly
illustrated and not buried among other less relevant
ﬁndings. Feedback to individual clinical teams should be
prompt so that it represents current practice, and is not at
risk of being dismissed as irrelevant because of subsequent
changes to the service. For example, the results of a local
audit of lithium monitoring on a small patient sample,
conducted several months ago, may be seen as only of
historical interest if there have been subsequent changes
such as the introduction of a local lithium database, a
change in case-load for the clinical team or the appointment
of a new consultant. Prioritising early dissemination of the
audit ﬁndings to the participating teams is likely to have
more impact on clinical practice than taking a more formal
and inevitably slower route through the trust’s governance
structures.
Changing clinical practice
Changing clinical practice can be a difﬁcult and slow
process. Experience from audit-based quality improvement
programmes conducted by POMH-UK suggests that it can
take up to 3 years to see change at a national level, and that
the magnitude of that change is generally modest.15,16
However, within the context of the POMH-UK programmes
some individual services have implemented change more
quickly and sustained the improvements made. Enabling
factors include the active engagement of clinical teams in
the audit process, as mentioned earlier, having a local
champion who supports and promotes the audit, effective
trust systems and infrastructure, and an organisational
culture of audit and quality improvement. Incentives for the
participation of psychiatrists include a desire to provide
best care, the use of audit evidence to support revalidation
and, for trainees, the achievement of intended learning
outcomes. Barriers to change include concern about being
exposed to external judgement, the audit ﬁndings not being
disseminated to participating clinical teams, limited support
or capacity to develop action plans and effect change, and
staff changes or service reorganisations that almost
inevitably result in a loss of continuity and momentum.
The potential for change will also be limited if a short-term
view is taken and the audit cycle is not completed. To
maximise the clinical impact of any audit it is important
that the cycle is followed: set standards, measure, reﬂect,
implement change, review standards, measure, reﬂect, etc.
It may take several cycles, testing and reﬁning change
interventions, to make and embed improvements in clinical
practice.
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